Macromolecular derivatives of N,N-di-(2-chloroethyl)-4-phenylenediamine mustard. 1. Synthesis and in vitro hydrolytic stability

Journal of Controlled Release

Volumn 45, Issue 3, 1997, Pages 235-247

  Soyez, Heidi ^a   Schacht, Etienne ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cancer chemotherapy; N,N Di (2 chloroethyl) 4 phenylenediamine mustard; Prodrugs; Tumour associated enzymes

Indexed keywords

CHLORMETHINE DERIVATIVE; OLIGOPEPTIDE; PHENYLENEDIAMINE DERIVATIVE; PRODRUG;

AMINO ACID SEQUENCE; ARTICLE; DRUG CONJUGATION; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG STABILITY; DRUG SYNTHESIS; LIGHT SCATTERING; PRIORITY JOURNAL;

EID: 0031058678     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01570-2     Document Type: Article

References (48)

1. H. Ringsdorf, Structure properties of pharmacologically active polymers, J. Polym. Sci. Polym. Symp. 51 (1975) 135-153.
2. D. Putnam and J. Kopecek, Polymer conjugates with anti-cancer activity. Adv. Polym. Sci. 3 (1995) 55-123.
3. R. Duncan, Drug-polymer conjugates: potential for improved chemotherapy, Anti-Cancer Drugs 3 (1992) 175-210.
4. C. De Duve, T. De Barsy, B. Pode, A. Trouet, P. Tulkens and F. Van Hoof, Lysosomotropic agents, Biochem. Pharmacol. 23 (1974) 2495-2531.
5. A.J. Barrett and M.F. Heath, Lysosomal enzymes. In: J.T. Dingle (Ed.), Lysosomes: A Laboratory Handbook, North-Holland, Amsterdam, 1977, pp. 19-145.
6. R. Duncan, H. Cable, J. Lloyd, P. Rejmanova and J. Kopecek, Degradation of side chains of N-(2-hydroxy-propyl)methacrylamide copolymers by lysosomal cysteine proteinases, Biosci. Rep. 2 (1981) 1041-1046.
7. V. Subr, J. Kopecek and R. Duncan, Degradation of oligopeptide sequences connecting N-(2-hydroxypropyl)-methacrylamide chains by lysosomal cysteine proteinases, J. Bioact. Compat. Polym. 1 (1986) 133-146.
8. V. Subr, J. Strohalm, K. Ulbrich, R. Duncan and I. Hume, Polymers containing enzymatically degradable bonds XII: Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly-[N-(2-hydroxypropyl)methacrylamide] copolymer drug carriers in vitro and antitumor activity measured in vivo, J. Control. Release 18 (1992) 123-132.
9. H. Maeda and Y. Matsumura, Tumoritropic and lymphotropic principles of macromolecular drugs, Crit. Rev. Ther. Drug Carrier Syst. 6 (1989) 183-210.
10. L. Seymour, Passive tumour-targeting of soluble macromolecules and drug conjugates, Crit. Rev. Ther. Drug Carrier Syst. 9 (1992) 135-187.
11. T.A. Connors and R.J. Knox, Prodrugs in cancer chemotherapy, Stem Cells 13 (1995) 501-511.
12. P. Mignatti and D.B. Rifkin, Biology and biochemistry of proteinases in tumor invasion, Physiol, Rev. 78 (1993) 161-187.
13. W. Steller-Stevenson, Type IV Collagenases in tumor invasion and metastasis, Cancer Metastasis Rev. 9 (1990) 289-303.
14. D. Keppler, M. Abrahamson and B. Sordat, Proteases and cancer: secretion of cathepsin B and tumour invasion, Biochem. Soc. Trans. 22 (1994) 43-68.
15. A. De Marre, L.W. Seymour and E. Schacht, Evaluation of the hydrolytic and enzymatic stability of macromolecular Mitomycin C derivatives, J. Control. Release 31 (1994) 89-97.
16. A. De Marre, H. Soyez, E. Schacht, M.A. Shoabi, L.W. Seymour and B. Rihova, Synthesis and evaluation of macromolecular prodrugs of Mitomycin C, J. Control. Release 36 (1995) 87-97.
17. [17[ R. Duncan, I.C. Hume, H.J. Yardley, P.A. Flanagan, K. Ulbrich, V. Subr and J. Strohalm, Macromolecular prodrugs for use in targeted chemotherapy: melphalan covalently coupled to N-(2-hydroxypropyl) methacrylamide copolymers, J. Control. Release 16 (1991) 121-136.
18. H. Soyez, E. Schacht, A. De Marre and L.W. Seymour, Polymeric prodrugs of Mitomycin C, In: Proceedings of the 5th Dresden Polymer Discussion: Polymers and Medicine Part I, 1995, pp. 159-172.
19. B.D. Palmer, W.R. Wilson, S. Cliffe and W.A. Denny, Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines, J. Med. Chem. 33 (1990) 112-121.
20. M.H. Benn, A.M. Creighton, L.N. Owen and G.R. White, Cytotoxic compounds Part II: Some amides of the nitrogen mustard type, J. Chem. Soc. (1961) 2365-2375.
21. W.C.J. Ross, O.P. Warwick and J.J. Roberts, Aryl-2-halogenoalkylamines Part XIV: Some compounds possessing latent cytotoxic activity, J. Chem. Soc. (1955) 3110-3116.
22. B.J. Johnson and L.N. Owen, Cytotoxic compounds Part VI. Some N′ [α-(aminoacyl]-N,N-di-2′-chloroethyl-p-phenylene-diamines, J. Chem. Soc. (1964) 3401-3404.
23. F. Bergel and J.A. Stock, Cyto-active amino-acids and peptides Part VI: Synthesis of N′-α-aminoacyl-N,N-di-(2-chloroethyl)-p-phenylenediamines. J. Chem. Soc. (1959) 97-99.
24. M. Szekerke, R. Wade and M.E. Whisson, The use of macromolecules as carriers of cytotoxic groups (Part I), Neoplasma 19 (1972) 199-209.
25. M. Szekerke, R. Wade and M.E. Whisson, The use of macromolecules as carriers of cytotoxic groups (Part II), Neoplasma 19 (1972) 211-215.
26. M.J. Marquisee and J.C. Kauer, Collagenase-sensitive peptidyl-nitrogen mustards as potential antitumor agents, J. Med. Chem. 21 (1978) 1184-1194.
27. P.K. Chakravarty, P.L. Carl, M.J. Weber and J.A. Katzenellenbogen, Plasmin-activated prodrugs for cancer chemotherapy: 1. Synthesis and biological activity of peptidyl-acivicin and peptidyl-phenylenediamine mustard, J. Med. Chem. 26 (1983) 633-638.
28. H. Maeda, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 6 (1991) 181-202.
29. A. Gerola, G. Antoni, F. Benvenuti, F. Cocola and P. Neri. In: Shock: Biochemical, Pharmacological and Clinical Aspects, Plenum Press, New York, 1970, 329 pp.
30. F. Rypacek, V. Saudek, J. Pytela, V. Skarda and J. Drobnik, Polyglutamines: versatile biodegradable carriers, Makromol. Chem. Suppl. 9 (1985) 129-135.
31. A. De Marre and E. Schacht, Preparation of 4-nitrophenyl carbonate esters of poly[N-(2-hydroxyethyl)-L-glutamine] and coupling with bioactive agents, Makromol. Chem. 193 (1992) 3023-3030.
32. J. Pytela, V. Saudek, J. Drobnik and F. Rypacek, Poly(N-hydroxyalkylglutamines) IV. Enzymatic degradation of N(2-hydroxyethyl)-L-glutamine homopolymers and copolymers, J. Control. Release 10 (1989) 17-25.
33. A. De Marre, H. Soyez, J. Pytela and E. Schacht, Improved method for the preparation of poly[N-(2-hydroxyethyl)-L-glutamine] by aminolysis of poly-(γ-benzylglutamate), Polymer 35 (1994) 2443-2446.
34. M. Bodansky and A. Bodansky, In: The Practice of Peptide Synthesis, Springer, Berlin, 1984.
35. J.L. Everett and W.C.J. Ross, Aryl-2-halogenoalkylamines Part II, J. Chem. Soc. (1949) 1972-1983.
36. M. Szekerke, R. Wade and F. Bergel, Cyto-active amino acids and peptides. Part XI. Nitrogen mustard derivatives of glutamic acid and related compounds, J. Chem. Soc. (1965) 1907-1912.
37. W.J.C. Ross, Aryl-2-halogenoalkylamines. Part I, J. Chem. Soc. (1949) 183-191.
38. P.D. Edwards, D.L.D. Foster, L.N. Owen and M.J. Pringle, Cytotoxic compounds. Part XVII. J. Chem. Soc., Perkin Trans. 20 (1973) 2397-2402.
39. V.K. Gupta, Kinetics and mechanism of oxidation of p-substituted anilines by peroxydisulfate ion in acetic acid-water medium. React. Kinet. Catal. Lett. 27 (1985) 207-211.
40. B. Wang, S. Liu and R.T. Borchordt, Development of a novel redox-sensitive protecting group for amines which utilizes a facilitated lactonization reaction, J. Org. Chem. 60 (1995) 539-543.
41. C. Dollery. In: Therapeutic Drugs, Churchill Livingstone, Edinburgh, 1991.
42. M. Nukui, K. Hoes, H. van den Berg and J. Feijen, Association of macromolecular prodrugs consisting of adriamycin bound to poly(L-glutamic acid), Makromol. Chem. 192 (1991) 2925-2942.
43. M. Yokayama, G.S. Kwon, T. Okano, Y. Sakurai, T. Seto and K. Kataoka, Preparation of micelle-forming polymer-drug conjugates, Bioconj. Chem. 3 (1992) 295-301.
44. K. Kataoka, Design of nanoscopic vehicles for drug targeting based on micellization of amphiphilic block copolymers, J.M.S. Pure Appl. Chem. A31 (1994) 1759-1769.
45. L. Liotta, K. Tryggvason, S. Garbisa, I. Hart, C. Foltz and S. Schaffie, Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature 284 (1980) 67-68.
46. T. Turpeenniemi-Hujanem, U. Thorgeisson and I. Hart, Expression of collagenase IV activity in murine tumour cell hybrids that differ in metastatic potential, J. Natl. Cancer Inst. 75 (1985) 99-103.
47. N. Guinec, V. Dalet-Fumeron and M. Pagano, In vitro study of basement membrane degradation by cysteine proteinases. Cathepsins B, B-like and L, Biol. Chem. Hoppe-Seyler 375 (1993) 1135-1146.
48. B.F. Sloane, K. Moin, E. Krepela and J. Rozhin, Cathepsin B and its endogenous inhibitors: the role in tumour malignancy. Cancer Metastasis Rev. 9 (1990) 333-352.